Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 17, 2024
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8<sup>+</sup> clonal effector and CAR T-cell function while promoting a senescence-associated phenotype
Russell Towers, Lidia Trombello, Maximilian Fusenig, et al.
Journal of Autoimmunity
|
March 6, 2018
Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology
Stefanie Koristka, Alexandra Kegler, Ralf Bergmann, et al.
Oncoimmunology
|
November 11, 2017
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model
Elham Pishali Bejestani, Marc Cartellieri, Ralf Bergmann, et al.
Frontiers in Immunology
|
January 3, 2024
Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells
Karla E G Soto, Liliana R Loureiro, Tabea Bartsch, et al.
Scientific Reports
|
February 17, 2017
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
Roberta Aliperta, Petra B Welzel, Ralf Bergmann, et al.
Cancers
|
October 13, 2021
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy
Enrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana Rodrigues Loureiro, et al.
Oncoimmunology
|
May 17, 2017
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
Susann Albert, Claudia Arndt, Anja Feldmann, et al.
Oncotarget
|
February 28, 2018
Retargeting of UniCAR T cells with an <i>in vivo</i> synthesized target module directed against CD19 positive tumor cells
Dominik Bachmann, Roberta Aliperta, Ralf Bergmann, et al.
Frontiers in Immunology
|
May 1, 2023
Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells
Haidy A Saleh, Nicola Mitwasi, Martin Ullrich, et al.
Oncotarget
|
April 14, 2017
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR"
Anja Feldmann, Claudia Arndt, Ralf Bergmann, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Cancer Immunology, Immunotherapy : CII
|
January 17, 2024
Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8<sup>+</sup> clonal effector and CAR T-cell function while promoting a senescence-associated phenotype
Russell Towers, Lidia Trombello, Maximilian Fusenig, et al.
Journal of Autoimmunity
|
March 6, 2018
Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology
Stefanie Koristka, Alexandra Kegler, Ralf Bergmann, et al.
Oncoimmunology
|
November 11, 2017
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model
Elham Pishali Bejestani, Marc Cartellieri, Ralf Bergmann, et al.
Frontiers in Immunology
|
January 3, 2024
Targeting colorectal cancer cells using AND-gated adaptor RevCAR T-cells
Karla E G Soto, Liliana R Loureiro, Tabea Bartsch, et al.
Scientific Reports
|
February 17, 2017
Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy
Roberta Aliperta, Petra B Welzel, Ralf Bergmann, et al.
Cancers
|
October 13, 2021
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy
Enrico Kittel-Boselli, Karla Elizabeth González Soto, Liliana Rodrigues Loureiro, et al.
Oncoimmunology
|
May 17, 2017
A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
Susann Albert, Claudia Arndt, Anja Feldmann, et al.
Oncotarget
|
February 28, 2018
Retargeting of UniCAR T cells with an <i>in vivo</i> synthesized target module directed against CD19 positive tumor cells
Dominik Bachmann, Roberta Aliperta, Ralf Bergmann, et al.
Frontiers in Immunology
|
May 1, 2023
Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells
Haidy A Saleh, Nicola Mitwasi, Martin Ullrich, et al.
Oncotarget
|
April 14, 2017
Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology "UniCAR"
Anja Feldmann, Claudia Arndt, Ralf Bergmann, et al.
Page
of 9